The company closed on a $58 million senior secured credit facility with Midcap Financial and Silicon Valley Bank. The credit facility is comprised of a $43 million term loan and a $15 million revolving line of credit.
“This financing, along with the proceeds from our recent IPO, strengthens our cash position and secures the availability of capital resources into 2019 as we drive the ongoing global commercial launch of Fuse and expand our platform of GI products and services,” said David N. Gill, CFO of EndoChoice.
More articles on gastroenterology:
David Hemink named president of Medivators
GI physician leader to know: Dr. Bruce Sands of Mount Sinai
William Blair gives EndoChoice ‘outperform’ rating: 4 notes
